Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01897064 · ClinicalTrials.gov registry record · NA
The Influence of Aerobic Exercise on Cognitive Functioning in Schizophrenia.
A NA study, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT01897064: Completed NA study, sponsored by New York State Psychiatric Institute.
NCT01897064 is a NA study that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 41 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01897064, a NA study, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
The aim of this study is to look at the effects of Aerobic Exercise (AE) on daily and neurocognitive functioning including memory, attention, the ability to plan activities, and learn new information. Participants will be assigned by chance to receive regular care or exercise sessions in addition to regular care. This study will allow determining the potential positive influence of AE on cognitive and daily functioning in individuals with schizophrenia.
Primary Outcome
Standardized battery designed to measure cognition specifically in individuals in schizophrenia.
Interventions
- BEHAVIORAL Aerobic Exercise
- OTHER Standard Psychiatric Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2012-04 |
| Est. Completion | 2014-07 |
| Phase | NA |
What the finished NCT01897064 record still lists
NCT01897064 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Aerobic Exercise is the first listed.
NCT01897064 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01897064 about?
NCT01897064 is a clinical study titled "The Influence of Aerobic Exercise on Cognitive Functioning in Schizophrenia.". The aim of this study is to look at the effects of Aerobic Exercise (AE) on daily and neurocognitive functioning including memory, attention, the ability to plan activities, and learn new information. Participants will be assigned by chance to receive regular care or exercise sessions in addition to...
What is the current status of trial NCT01897064?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2012-04. Estimated completion is 2014-07.
What interventions are being tested in trial NCT01897064?
The interventions under investigation include: Aerobic Exercise (BEHAVIORAL), Standard Psychiatric Treatment (OTHER).
Who is sponsoring clinical trial NCT01897064?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01897064's enrollment target sits among peer trials
41 1446th of 2000 higher than 554 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia